Transaminase and application thereof

By recombining the omega-transmissible aminotransferase gene of Streptococcus thermophilus in Escherichia coli, the existing omega-transmissible aminotransferases are solved, and the efficiency of existing omega-transmissible aminotransferases is achieved. The high efficiency of fat ketones, aromatic ketones and other compounds is achieved Convert to chiral amines, with the characteristics of industrial application and efficient catalytic capabilities.

CN118979024AInactive Publication Date: 2024-11-19TAIZHOU LINGJIANG BIOTECHNOLOGY CO LTD
View PDF 6 Cites 0 Cited by

Patent Information

Application Number
CN202411107455.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-13
Publication Date
2024-11-19
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The existing ω-transaminases have shortcomings in substrate specificity, stability and catalytic efficiency, which are difficult to meet the needs of industrial applications, especially in the synthesis of chiral amines, which have problems such as heavy metal pollution, poor stereoselectivity and low yield.

Method used

Cloned the omega-transaminase gene sequence of Streptococcus thermophilus, recombinantly expressed in E. coli, designed PCR primers for gene amplification, and ligated the gene to the PET vector to obtain an industrially applicable transaminase, which exhibits a wide substrate The characteristics of spectrum, high temperature resistance, high pH, ​​and catalyze the water-insoluble substrate by immobilizing aminotransferase.

Benefits of technology

It realizes efficient conversion of carbonyl-containing compounds such as fatty ketones and aromatic ketones into chiral amine compounds, which is reusable and suitable for industrial applications, and improves catalytic efficiency and chiral purity of products.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004991226100000031
    Figure BDA0004991226100000031
Patent Text Reader

Abstract

The invention belongs to the field of synthetic biology, and particularly relates to transaminase, the amino acid sequence of the transaminase is shown as SEQ ID NO.2, and the sequence is coded by SEQ ID NO.1. A preparation method of the transaminase comprises the following steps: (1) designing a PCR (Polymerase Chain Reaction) forward primer shown as SEQ ID NO.3 and a PCR reverse primer shown as SEQ ID NO.4 according to an omega-transaminase gene sequence of streptococcus thermophilus disclosed in GenBank; (2) carrying out colony PCR amplification by taking the DNA of the streptococcus thermophilus as a template to obtain an omega-transaminase gene of the streptococcus thermophilus; and (3) connecting the gene as shown in SEQ ID NO.1 to a PET carrier, and transferring into escherichia coli to obtain a recombinant strain which expresses the transaminase polypeptide as shown in SEQ ID NO.2. The invention also provides an application of the transaminase. The omega-transaminase gene sequence of streptococcus thermophilus is cloned, the transaminase capable of being industrially applied is obtained through recombinant expression in escherichia coli, and the transaminase has the characteristics of wide substrate spectrum, high temperature resistance and high pH.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the field of synthetic biology, and in particular relates to a transaminase and an application thereof. Background Art

[0002] Transaminase, also known as aminotransferase, is a type of polypeptide that catalyzes the reversible transfer of amino groups between amino compounds and carbonyl compounds. There are many types of transaminases, which can be divided into three categories according to the different substrates: (1) L-α-transaminase, which uses α-amino acids as substrates; (2) D-transaminase, which often uses D-amino acids as substrates; (3) ω-transaminase, which refers to the enzyme-catalyzed transamination reaction in which the substrate or product does not contain α-amino acids. The ω-transaminase is widely distributed in the EC numbering, such as acetyl-ornithine aminotransferase (EC2.6.1.11), 4-aminobutyrate-pyruvate aminotransferase (EC2.6.1.19), β-alanine-pyruvate aminotransferase (EC2.6.1.18), etc. In the field of biocatalysis, ω-transaminase has attracted much attention. ω-aminotransferases can be widely used in the regioselective and stereoselective transamination reactions of substrates such as aliphatic and aromatic keto acids, aldehydes, ketones and ketoses to synthesize chiral amines, amino acids and their derivatives. ω-aminotransferases provide a unique opportunity for the asymmetric synthesis of bioactive compounds with chiral amine structural fragments, most of which start from prochiral ketones or low-cost racemic amines. The asymmetric catalytic synthesis of chiral amines using ω-aminotransferases can avoid the defects of existing chiral amine synthesis technologies, such as heavy metal pollution, poor stereoselectivity, and low yield. With the continuous expansion of the chiral drug market, the demand for chiral amines has grown rapidly. ω-aminotransferases have good application prospects in the synthesis of chiral amines. However, due to the many deficiencies of wild-type enzymes in terms of substrate specificity, stability, catalytic efficiency, etc., the ω-aminotransferases that meet the needs of industrial applications are still relatively limited.

[0003] Chinese patent CN102341494A (publication date: 2012-02-01) reports that the ω-aminotransferase from Vibrio fluviatilis can catalyze the conversion of various carbonyl compounds into chiral amine compounds after genetic modification.

[0004] US Patent No. 8293507B2 (publication date: 2012-10-23) reported that ω-aminotransferase from Arthrobacter can replace rhodium catalyst for the synthesis of sitagliptin. Compared with chemical synthesis methods, the conversion rate and chiral purity of the product are greatly improved.

[0005] Chinese patents CN111411095 A (publication date: 2020-07-14) and CN111041019 A (publication date: 2020-04-21) both reported that ω-aminotransferases from different sources were used to synthesize sitagliptin. Summary of the invention

[0006] In view of the deficiencies in the prior art, the present invention provides a transaminase and its application, clones the ω-transaminase gene sequence of thermophilic Streptococcus, and recombinantly expresses it in Escherichia coli to obtain an industrially applicable transaminase, which exhibits the characteristics of a wide substrate spectrum, high temperature resistance and high pH.

[0007] In order to solve the above technical problems, the purpose of the present invention is achieved through the following technical solutions:

[0008] A transaminase, the amino acid sequence of the transaminase is shown in SEQ ID NO.2, and the sequence is encoded by SEQ ID NO.1.

[0009] The above transaminase is prepared by the following method:

[0010] (1) According to the ω-aminotransferase gene sequence of Streptococcus thermophilus published in GenBank, a PCR forward primer as shown in SEQ ID NO.3 and a PCR reverse primer as shown in SEQ ID NO.4 were designed;

[0011] Forward: CGGGATCCATGTATCTGATGAACAC;

[0012] Reverse:CCCAAGCTTTTAAATTCCTTGCAGGAC;

[0013] (2) using the DNA of Streptococcus thermophilus as a template for colony PCR amplification to obtain the ω-aminotransferase gene of Streptococcus thermophilus as shown in SEQ ID NO.1;

[0014] (3) The gene obtained in step (2) as shown in SEQ ID NO.1 is connected to a pET vector and transformed into Escherichia coli to obtain a recombinant strain, which expresses the transaminase polypeptide as shown in SEQ ID NO.2; the method for connecting the gene to the vector is a conventional method for molecular cloning.

[0015] The present invention also provides the use of the transaminase: in an aqueous phase containing an organic solvent, in the presence of an amino donor and a coenzyme pyridoxal phosphate, the transaminase shown in SEQ ID NO.2 converts a carbonyl-containing compound into a chiral amine compound.

[0016] In the above-mentioned application of a transaminase, the organic solvent is selected from methanol, ethanol, DMF, and DMSO.

[0017] In the above-mentioned application of a transaminase, the amino donor is selected from isopropylamine, glycine, and alanine.

[0018] In the above-mentioned application of a transaminase, the carbonyl-containing compound is selected from aliphatic ketones or aromatic ketones.

[0019] Table 1 Application of transaminase

[0020]

[0021] Table 1 lists some applications of the transaminase of the present invention. The carbonyl-containing compounds are aliphatic ketones: 3-octanone, 4-octanone, and 2-octanone; aromatic ketones: acetophenone, 3-(naphthalen-1-yloxy)-1-phenylpropane-1-one, and 4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7-(8h)-yl]-1-(2,4,5-trifluorophenyl)butan-2-one.

[0022] The present invention can be used to prepare the chiral amine compound dapoxetine by converting the carbonyl group in the carbonyl-containing compound 3-(naphthalen-1-yloxy)-1-phenylpropane-1-one into a chiral amine.

[0023] The present invention can be used to prepare a chiral amine compound, sitagliptin, by converting the carbonyl group in a carbonyl-containing compound, 4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7-(8h)-yl]-1-(2,4,5-trifluorophenyl)butan-2-one, into a chiral amine.

[0024] The transaminase of the present invention can be further immobilized and then used, which specifically includes the following steps:

[0025] (1) Immobilization of transaminase, wherein the recombinant strain is subjected to fermentation, induction, centrifugation, cell disruption, and flocculation to obtain a transaminase solution; under neutral conditions, a macroporous adsorption resin is added, and the immobilized transaminase is obtained after stirring at room temperature for several hours; the polymer monomer of the macroporous adsorption resin skeleton is selected from styrene, acrylic acid, etc.;

[0026] (2) Application of immobilized transaminase: After the transaminase is immobilized, it reacts in an organic phase and, in the presence of an amino donor and the coenzyme pyridoxal phosphate, converts a carbonyl-containing compound into a chiral amine compound.

[0027] The above-mentioned immobilized transaminase adopts an organic phase, which is more suitable for catalyzing water-insoluble substrates, and the immobilized transaminase can be repeatedly used.

[0028] The application of the above-mentioned immobilized transaminase further includes: adding a substrate into a reactor, dissolving it with a certain volume of solvent, the solvent used can be one or more of water, methanol, ethanol, isopropanol, ethyl acetate, isopropyl acetate, toluene, adding an immobilized enzyme and an amino donor, the amino donor can be glycine, alanine, glutamic acid, isopropylamine, phenylethylamine, etc., the coenzyme is pyridoxal phosphate, reacting under stirring at a certain temperature, and stopping the reaction after reaching the desired conversion rate. Filtering and removing the reaction solution, the immobilized enzyme is repeatedly applied in the same way.

[0029] Compared with the prior art, the present invention has the following beneficial effects:

[0030] 1. The present invention provides a new transaminase, which uses the ω-transaminase gene sequence (SEQ ID NO.1) from thermophilic Streptococcus to recombinantly express in Escherichia coli to obtain an industrially applicable transaminase, which can be used to convert aliphatic ketones, aromatic ketones and other carbonyl-containing compounds into chiral amine compounds. The transaminase exhibits the characteristics of a wide substrate spectrum, high temperature resistance and high pH.

[0031] 2. The present invention further immobilizes the transaminase, which can be used to catalyze water-insoluble substrates, and the immobilized transaminase can be reused. DETAILED DESCRIPTION

[0032] The present invention is further illustrated below through the description of specific implementation methods, but this is not a limitation of the present invention. Those skilled in the art can make various modifications or improvements based on the basic idea of ​​the present invention, but as long as they do not deviate from the basic idea of ​​the present invention, they are all within the scope of the present invention.

[0033] Unless otherwise specified, all raw materials and reagents used in the examples of the present invention were purchased from commercial sources.

[0034] Example 1

[0035] Preparation of transaminase enzyme solution

[0036] (1) Transaminase gene cloning

[0037] Design synthetic primers:

[0038] Forward: CGGGATCCATGTATCTGATGAACAC

[0039] Reverse:CCCAAGCTTTTAAATTCCTTGCAGGAC

[0040] The ω-aminotransferase gene of Streptococcus thermophilus was obtained by colony PCR amplification using DNA of Streptococcus thermophilus as template.

[0041] (2) Transaminase expression

[0042] According to conventional molecular cloning methods, the gene amplified by PCR is connected to a PET vector and transferred into Escherichia coli to obtain a recombinant strain. The recombinant bacteria undergo fermentation, induction, centrifugation, cell disruption, flocculation and other processes to obtain a transaminase enzyme solution.

[0043] (3) Preparation of transaminase enzyme solution

[0044] Preparation of strains: The sequence 1 gene was connected to the PET vector according to conventional molecular cloning methods and transferred into Escherichia coli to obtain a recombinant strain. The strain was frozen and stored at -80°C with 30% glycerol solution.

[0045] Activation of bacterial strains: Streak the bacterial strains on LB medium plates and culture at 37°C for 24 hours.

[0046] Fermentation: According to the conventional fermentation method of recombinant Escherichia coli, the fermentation liquid is obtained through seed fermentation, fermentation, induction and other processes.

[0047] Preparation of enzyme solution: The fermentation broth was concentrated with a microfiltration membrane, the bacteria were broken with a high-pressure homogenizer (80 MPa), flocculated with chitosan, centrifuged at 6000 rpm with a refrigerated centrifuge for 30 min, and the supernatant was collected as the enzyme solution.

[0048] Example 2

[0049] Application of transaminase (I)

[0050] The enzyme solution used in this example was prepared from Example 1

[0051] Add 100g of water to the reactor, add isopropylamine hydrochloride to a concentration of 4mol / L, heat to 45°C, add 50ml of methanol, stir and add 10ml of enzyme solution and 0.05g of pyridoxal phosphate, adjust the pH to 8.5 with 50% isopropylamine solution, slowly dropwise add 3-octanone methanol solution (20g 3-octanone + 20ml methanol), maintain the reaction solution pH to 8.5 with 50% isopropylamine solution, and the conversion rate can be greater than 99% within 24 hours.

[0052] Example 3

[0053] Application of transaminase (II)

[0054] The enzyme solution used in this example was prepared from Example 1

[0055] Add 100 g of water to the reactor, add isopropylamine hydrochloride to a concentration of 4 mol / L, heat to 45°C, add 50 ml of methanol, stir and add 10 ml of enzyme solution and 0.05 g of pyridoxal phosphate, adjust the pH to 8.5 with 50% isopropylamine solution, slowly dropwise add a methanol solution of acetophenone (20 g of acetophenone + 20 ml of methanol), maintain the pH of the reaction solution at 8.5 with 50% isopropylamine solution, and the conversion rate can be greater than 95% within 24 hours.

[0056] Example 4

[0057] Application of transaminase (III)

[0058] The enzyme solution used in this example was prepared from Example 1

[0059] Add 100 g of water to the reactor, add isopropylamine hydrochloride to a concentration of 4 mol / L, heat to 45° C., add 50 ml of methanol, stir and add 10 ml of enzyme solution and 0.05 g of pyridoxal phosphate, adjust the pH to 8.5 with 50% isopropylamine solution, slowly dropwise add a methanol solution of 3-(naphthalene-1-yloxy)-1-phenylpropane-1-one (20 g of ketone + 20 g of methanol), maintain the pH of the reaction solution to 8.5 with 50% isopropylamine solution, and the conversion rate can be greater than 86% within 24 hours.

[0060] Example 5

[0061] Application of transaminase (IV)

[0062] The enzyme solution used in this example was prepared from Example 1

[0063] Add 100 g of water to the reactor, add isopropylamine hydrochloride to 4 mol / L, heat to 45°C, add 50 ml of methanol, stir and add 10 ml of enzyme solution and 0.05 g of pyridoxal phosphate, adjust the pH to 8.5 with 50% isopropylamine solution, slowly dropwise add 4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7-(8h)-yl]-1-(2,4,5-trifluorophenyl)butan-2-one methanol solution (20 g ketone + 40 ml of methanol), maintain the reaction solution pH to 8.5 with 50% isopropylamine solution, and the conversion rate can be greater than 95% within 24 hours.

[0064] Example 6

[0065] Transaminase immobilization

[0066] 100 g of commercially available HZ818 macroporous adsorption resin was added to the reactor, and 200 g of transaminase enzyme solution was added. The mixture was stirred at room temperature for 24 hours, filtered, and the filter cake was rinsed with deionized water to obtain the immobilized transaminase.

[0067] Example 7

[0068] Application of immobilized transaminase (I)

[0069] The enzyme solution used in this example was prepared from Example 6

[0070] Add 20 g of substrate 3-octanone and 80 ml of isopropyl acetate to the reactor, stir and dissolve, add 20 g of immobilized transaminase and 0.05 g of pyridoxal phosphate, add 8 ml of isopropylamine, heat to 55°C, and keep warm for 20 hours. The conversion rate can be greater than 99%.

[0071] Example 8

[0072] Application of immobilized transaminase (II)

[0073] The enzyme solution used in this example was prepared from Example 6

[0074] Add 20 g of substrate acetophenone and 80 ml of isopropyl acetate to the reactor, stir and dissolve, add 20 g of immobilized transaminase and 0.05 g of pyridoxal phosphate, add 8 ml of isopropylamine, raise the temperature to 55°C, and keep the reaction for 20 hours. The conversion rate can be greater than 95%.

[0075] Example 9

[0076] Application of immobilized transaminase (Part 3)

[0077] The enzyme solution used in this example was prepared from Example 6

[0078] Add 20 g of substrate 3-(naphthalene-1-yloxy)-1-phenylpropane-1-one to the reactor, add 80 ml of isopropyl acetate, stir to dissolve, add 20 g of immobilized transaminase and 0.05 g of pyridoxal phosphate, add 10 ml of isopropylamine, raise the temperature to 55°C, and keep the reaction warm for 20 hours. The conversion rate can be greater than 86%.

[0079] Example 10

[0080] Application of immobilized transaminase (IV)

[0081] The enzyme solution used in this example was prepared from Example 6

[0082] Add 20 g of substrate 4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7-(8h)-yl]-1-(2,4,5-trifluorophenyl)butan-2-one into the reactor, add 80 ml of isopropyl acetate, stir to dissolve, add 20 g of immobilized transaminase and 0.05 g of pyridoxal phosphate, add 10 ml of isopropylamine, heat to 55°C, keep warm for reaction for 20 hours, and the conversion rate can be greater than 95%.

[0083] The above embodiments are only preferred embodiments of the present invention and are not intended to limit the protection scope of the present invention. Therefore, all equivalent changes made according to the present invention should be included in the protection scope of the present invention.

Claims

1. A transaminase, characterized in that The amino acid sequence of the transaminase is shown in SEQ ID NO.2, which is encoded by SEQ ID NO.

1.

2. A transaminase according to claim 1, characterized in that: The transaminase is prepared by the following method: (1) According to the ω-aminotransferase gene sequence of Streptococcus thermophilus published in GenBank, a PCR forward primer as shown in SEQ ID NO.3 and a PCR reverse primer as shown in SEQ ID NO.4 were designed; (2) using the DNA of Streptococcus thermophilus as a template for colony PCR amplification to obtain the ω-aminotransferase gene of Streptococcus thermophilus as shown in SEQ ID NO.2; (3) The gene obtained in step (2) as shown in SEQ ID NO.1 is connected to a pET vector and transformed into Escherichia coli to obtain a recombinant strain, which expresses the transaminase polypeptide as shown in SEQ ID NO.

2.

3. An application of a transaminase, characterized in that: The transaminase according to claim 1 converts a carbonyl-containing compound into a chiral amine compound in the presence of an amino donor and a coenzyme pyridoxal phosphate in an aqueous phase containing an organic solvent.

4. The use of a transaminase according to claim 3, characterized in that: The organic solvent is selected from methanol, ethanol, DMF and DMSO.

5. The use of a transaminase according to claim 3, characterized in that: The amino donor is selected from isopropylamine, glycine and alanine.

6. The use of a transaminase according to claim 3, characterized in that: The carbonyl-containing compound is selected from aliphatic ketones or aromatic ketones.

7. The use of a transaminase according to claim 3, characterized in that: The carbonyl-containing compound is 4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7-(8h)-yl]-1-(2,4,5-trifluorophenyl)butan-2-one, and the chiral amine compound is sitagliptin.

8. An application of a transaminase, characterized in that: The following steps are involved: (1) Immobilization of transaminase, wherein the recombinant strain obtained in claim 2 is subjected to fermentation, induction, centrifugation, cell disruption, and flocculation to obtain a transaminase solution; under neutral conditions, a macroporous adsorption resin is added, and the immobilized transaminase is obtained after stirring at room temperature for several hours; (2) Application of immobilized transaminase: After the transaminase is immobilized, it reacts in an organic phase and, in the presence of an amino donor and the coenzyme pyridoxal phosphate, converts a carbonyl-containing compound into a chiral amine compound.

Citation Information

Patent Citations

  • Recombinant transaminase and application thereof

    CN106995808A

  • Novel recombinant (R)-omega-transaminase, and mutant and applications of recombinant (R)-omega-transaminase

    CN111411095A

  • Transaminase, immobilized transaminase and application thereof

    CN117946992A